AAPS Advances in the Pharmaceutical Sciences Series

Challenges in Protein Product Development

Editors: Warne, Nicholas W., Mahler, Hanns-Christian (Eds.)

  • Discusses the challenges faced in biotechnology dosage form development
  • Provides practical and applied guidance in many areas including stability, microbiology and manufacturing, as well as case studies in life-cycle management
  • Includes comprehensive information on the use of polysorbate exipients in formulation   
おすすめポイントをすべて見る

書籍の購入

イーブック ¥25,505
価格の適用国: Japan (日本円価格は個人のお客様のみ有効) (小計)
  • ISBN 978-3-319-90603-4
  • ウォーターマーク付、 DRMフリー
  • ファイル形式: PDF, EPUB
  • どの電子書籍リーダーからでもすぐにお読みいただけます。
  • ご購入後、すぐにダウンロードしていただけます。
ハードカバー ¥31,882
価格の適用国: Japan (日本円価格は個人のお客様のみ有効) (小計)
  • ISBN 978-3-319-90601-0
  • 個人のお客様には、世界中どこでも配送料無料でお届けします。
  • Usually dispatched within 3 to 5 business days.
この書籍について

In this volume, the authors discuss the many significant challenges currently faced in biotechnology dosage form development, providing guidance, shared experience and thoughtful reflection on how best to address these potential concerns. As the field of therapeutic recombinant therapeutic proteins enters its fourth decade and the market for biopharmaceuticals becomes increasingly competitive, companies are increasingly dedicating resources to develop innovative biopharmaceuticals to address unmet medical needs. Often, the pharmaceutical development scientist is encountering challenging pharmaceutical properties of a given protein or by the demands placed on the product by stability, manufacturing and preclinical or clinical expectations, as well as the evolving regulatory expectations and landscape. Further, there have been new findings that require close assessment, as for example those related to excipient quality, processing, viscosity and device compatibility and administration, solubility and opalescence and container-closure selection. The literature varies widely in its discussion of these critical elements and consensus does not exist. This topic is receiving a great deal of attention within the biotechnology industry as well as with academic researchers and regulatory agencies globally. Therefore, this book is of interest for business leaders, researchers, formulation and process development scientists, analytical scientists, QA and QC officers, regulatory staff, manufacturing leaders and regulators active in the pharmaceutical and biotech industry, and expert reviewers in regulatory agencies.

著者について

Nicholas W. Warne is currently Senior Director of Formulations and Drug Product Process Development at Pfizer.  Dr. Warne has 28 years of industrial experience focusing on biologics formulation development, dosage form design and manufacturing process development.  He and his team have been fortunate to have contributed to the licensure of 10 biologics including clotting factors, growth proteins, mabs, vaccines and ADCs.  Dr. Warne holds numerous protein formulation patents and, with his group, has made over 100 presentations at national meetings and in journals.  Prior to his position at Pfizer, Dr. Warne had positions of increasing responsibility at Wyeth and Genetics Institute, and has been based in Andover, Massachusetts.

Dr. Warne received his PhD in Chemistry from Purdue University under the guidance of Professor Michael Laskowski Jr. He received his BS in Biochemistry, with Distinction in Research, from the University of Rochester. 

Hanns-Christian Mahler. Since September 2015, Dr. Mahler is leading the Drug Product services organization at Lonza AG, a leading service provider for the Pharma and Biotech industry. Prior this position, he led the department Pharmaceutical Development & Supplies, Biologics EU at Roche, Basel, Switzerland from 2010 to 2015 and as Head of Formulation R&D Biologics, Roche, Basel, from 2005 to 2010. From 2000-2005, Dr. Mahler was working at Merck KGaA, Darmstadt, Germany as Principal Formulation Scientist, Lab Manager for Protein Formulation Development and Clinical Trial Manufacturing and CMC Team leader for Erbitux during its submission and launch phase.

Dr. Mahler studied Pharmacy at the University of Mainz, Germany, holds in Ph.D. in Toxicology from the Institute of Pharmacy, University of Mainz and Pharmacist specialization degrees in Toxicology & Ecology and Pharmaceutical Technology. He was further trained in Economy and Marketing. Dr. Mahler obtained his venia legendi (german Habilitation) from the University of Frankfurt/Germany in 2010 and is adjunct faculty and lecturer at the universities of Frankfurt (Germany), and Basel (Switzerland). He was elected an AAPS Fellow in November 2013, nominated extraordinary Professor for Pharmaceutical Technology in November 2015 and received the PDA Distinguished Service Award in 2018.

Table of contents (26 chapters)

  • Introduction into Formulation Development of Biologics

    Weinbuch, Daniel (et al.)

    Pages 3-22

  • Polysorbate Degradation and Quality

    Ravuri, Kishore S. K.

    Pages 25-62

    Preview Buy Chapter ¥3,412
  • Sucrose and Trehalose in Therapeutic Protein Formulations

    Singh, Satish K.

    Pages 63-95

    Preview Buy Chapter ¥3,412
  • Introduction to High-Concentration Proteins

    Wang, Wei (et al.)

    Pages 99-123

    Preview Buy Chapter ¥3,412
  • Solubility, Opalescence, and Particulate Matter

    Mahler, Hanns-Christian (et al.)

    Pages 125-137

書籍の購入

イーブック ¥25,505
価格の適用国: Japan (日本円価格は個人のお客様のみ有効) (小計)
  • ISBN 978-3-319-90603-4
  • ウォーターマーク付、 DRMフリー
  • ファイル形式: PDF, EPUB
  • どの電子書籍リーダーからでもすぐにお読みいただけます。
  • ご購入後、すぐにダウンロードしていただけます。
ハードカバー ¥31,882
価格の適用国: Japan (日本円価格は個人のお客様のみ有効) (小計)
  • ISBN 978-3-319-90601-0
  • 個人のお客様には、世界中どこでも配送料無料でお届けします。
  • Usually dispatched within 3 to 5 business days.
Loading...

あなたへのおすすめ

Loading...

書誌情報

Bibliographic Information
Book Title
Challenges in Protein Product Development
Editors
  • Nicholas W. Warne
  • Hanns-Christian Mahler
Series Title
AAPS Advances in the Pharmaceutical Sciences Series
Series Volume
38
Copyright
2018
Publisher
Springer International Publishing
Copyright Holder
American Association of Pharmaceutical Scientists
イーブック ISBN
978-3-319-90603-4
DOI
10.1007/978-3-319-90603-4
ハードカバー ISBN
978-3-319-90601-0
Series ISSN
2210-7371
Edition Number
1
Number of Pages
XVI, 599
Number of Illustrations
55 b/w illustrations, 75 illustrations in colour
Topics